Tanner C - Search Results

1

The epidemiology of Parkinson's disease.

Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. Ben-Shlomo Y, et al. Among authors: tanner c. Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8. Lancet. 2024. PMID: 38245248 Review.

2

Liver enzyme abnormalities in Parkinson's disease.

Tanner CM. Tanner CM. Geriatrics. 1991 Aug;46 Suppl 1:60-3. Geriatrics. 1991. PMID: 1894148 Review.

3

Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look.

Tanner CM. Tanner CM. Neurology. 1991 May;41(5 Suppl 2):89-91; discussion 92. doi: 10.1212/wnl.41.5_suppl_2.89. Neurology. 1991. PMID: 2041601 Review.

4

Smell identification ability in twin pairs discordant for Parkinson's disease.

Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. Marras C, et al. Among authors: tanner cm. Mov Disord. 2005 Jun;20(6):687-93. doi: 10.1002/mds.20389. Mov Disord. 2005. PMID: 15719425

5

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE; Parkinson Study Group DATATOP Investigators. Marras C, et al. Among authors: tanner cm. Mov Disord. 2008 Apr 15;23(5):653-9; quiz 776. doi: 10.1002/mds.21853. Mov Disord. 2008. PMID: 18076084

6

Occupation and risk of parkinsonism: a multicenter case-control study.

Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Tanner CM, et al. Arch Neurol. 2009 Sep;66(9):1106-13. doi: 10.1001/archneurol.2009.195. Arch Neurol. 2009. PMID: 19752299

7

Urate as a predictor of the rate of clinical decline in Parkinson disease.

Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA; Parkinson Study Group DATATOP Investigators. Ascherio A, et al. Among authors: tanner cm. Arch Neurol. 2009 Dec;66(12):1460-8. doi: 10.1001/archneurol.2009.247. Arch Neurol. 2009. PMID: 19822770 Free PMC article. Clinical Trial.

8

Clinical features in early Parkinson disease and survival.

Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK. Lo RY, et al. Arch Neurol. 2009 Nov;66(11):1353-8. doi: 10.1001/archneurol.2009.221. Arch Neurol. 2009. PMID: 19901166

9

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.

Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I; Parkinson Study Group DATATOP and PRECEPT investigators. Marras C, et al. Mov Disord. 2009 Dec 15;24(16):2370-8. doi: 10.1002/mds.22828. Mov Disord. 2009. PMID: 19908310 Clinical Trial.

10

Advances in environmental epidemiology.

Tanner CM. Tanner CM. Mov Disord. 2010;25 Suppl 1:S58-62. doi: 10.1002/mds.22721. Mov Disord. 2010. PMID: 20187243 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

930 results

Search Page